Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. The Israel's Total Liabilities for the quarter that ended in Mar. 2026 was $7,397 Mil. The Israel's Total Assets for the quarter that ended in Mar. 2026 was $14,231 Mil.
Therefore, The Israel's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2026 was 0.52.
The Israel (OTCPK:IRLCF) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
The Israel Liabilities-to-Assets Related Terms
The Israel Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for The Israel's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRLCF vs LIN, SHW, ECL: Liabilities-to-Assets Comparison
For the Specialty Chemicals subindustry, The Israel's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel Liabilities-to-Assets vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where The Israel's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
The Israel's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Israel (IRLCF) has a Liabilities-to-Assets of 0.52 as of Mar. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on The Israel and its competitors.
Is The Israel's Liabilities-to-Assets too high?
The Israel's current Liabilities-to-Assets is 0.52. Overall, The Israel has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Israel's Liabilities-to-Assets compare to LIN and SHW?
The Israel's Liabilities-to-Assets of 0.52 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Chemicals company?
A good Liabilities-to-Assets depends on the Chemicals industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on The Israel and its competitors. The Israel's current Liabilities-to-Assets is 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
Based on GuruFocus' analysis, The Israel (IRLCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.15, compared to a current price of $28.00 — trading 10.1% below its estimated fair value. The current Liabilities-to-Assets is 0.52. The Israel's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For The Israel (IRLCF), the current Liabilities-to-Assets is 0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $28.00 is trading 10.1% below its estimated GF Value™ of $31.15.
GuruFocus considers The Israel to be Modestly Undervalued.
Key valuation signals for IRLCF:
Liabilities-to-Assets: 0.52
GF Value™: $31.15 vs. price of $28.00 (10.1% below fair value)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
67GF Score
Get the complete analysis for IRLCF
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
